Skip to Main Content

NISH (NITAG Support Hub) 6: Hepatitis A vaccines: Systematic Reviews

This Library Guide is a collection of useful documents & evidence on the efficacy, effectiveness and impact of the Hepatitis A vaccine to support NITAG members and other policy makers throughout Africa with making evidence-based recommendations.

Systematic Reviews on Hep A Vaccines

Gabrielli, F., Alberti, F., Russo, C., Cursaro, C., Seferi, H., Margotti, M., & Andreone, P. (2023). Treatment options for hepatitis A and E: a non-systematic review. Viruses, 15(5), 1080. https://doi.org/10.3390/v15051080

Andani, A., van Damme, P., Bunge, E. M., Salgado, F., van Hoorn, R. C., & Hoet, B. (2022). One or two doses of hepatitis A vaccine in universal vaccination programs in children in 2020: A systematic review. Vaccine, 40(2), 196–205. https://doi.org/10.1016/j.vaccine.2021.01.038

Gurav, Y. K., Bagepally, B. S., Thakkinstian, A., & Thavorncharoensap, M. (2022). Economic evaluation of hepatitis A vaccines by income level of the country: A systematic review. Indian Journal of Medical Research, 156(3), 388-410.  DOI: 10.4103/ijmr.IJMR_1631_20

Herzog, C., Van Herck, K., & Van Damme, P. (2021). Hepatitis A vaccination and its immunological and epidemiological long-term effects–a review of the evidence. Human Vaccines & Immunotherapeutics, 17(5), 1496–1519. https://doi.org/10.1080/21645515.2020.1819742

Patterson, J., Abdullahi, L., Hussey, G. D., Muloiwa, R., & Kagina, B. M. (2019). A systematic review of the epidemiology of hepatitis A in Africa. BMC Infectious Diseases, 19(1), 651  https://doi.org/10.1186/s12879-019-4235-5

Link-Gelles, R., Hofmeister, M. G., & Nelson, N. P. (2018). Use of hepatitis A vaccine for post-exposure prophylaxis in individuals over 40 years of age: A systematic review of published studies and recommendations for vaccine use. Vaccine, 36(20), 2745–2750. (NOT OA)

Stuurman, A. L., Marano, C., Bunge, E. M., De Moerlooze, L., & Shouval, D. (2017). Impact of universal mass vaccination with monovalent inactivated hepatitis A vaccines–a systematic review. Human Vaccines & Immunotherapeutics, 13(3), 724–736. https://doi.org/10.1080/21645515.2016.1242539

Irving, G. J., Holden, J., Yang, R., & Pope, D. (2012). Hepatitis A immunisation in persons not previously exposed to hepatitis A. Cochrane Database of Systematic Reviews, 7. https://doi.org/10.1002/14651858.CD009051.pub2

Ott, J. J., Irving, G., & Wiersma, S. T. (2012). Long-term protective effects of hepatitis A vaccines. A systematic review. Vaccine, 31(1), 3–11. https://doi.org/10.1016/j.vaccine.2012.04.104

Bianco, E., De Masi, S., Mele, A., & Jefferson, T. (2004). Effectiveness of immune globulins in preventing infectious hepatitis and hepatitis A: a systematic review. Digestive and Liver Disease, 36(12), 834–842. (NOT OA)

Demicheli, V., & Tiberti, D. (2003). The effectiveness and safety of hepatitis A vaccine: A systematic review. Vaccine, 21(19–20), 2242–2245. (NOT OA)

Retrieved from SYSVAC

Horn, E. K., Herrera-Restrepo, O., Acosta, A. M., Simon, A., Jackson, B., & Lucas, E. (2024). The Burden of Hepatitis A Outbreaks in the United States: health outcomes, economic costs, and management strategies. The Journal of infectious diseases, 230(1), e199-e218. https://doi.org/10.1093/infdis/jiae087

Allison, L. E., Alhaffar, M., Checchi, F., Abdelmagid, N., Nor, B., Sabahelzain, M. M., ... & Singh, N. S. (2023). A systematic review of vaccination guidance for humanitarian responses. Vaccines, 11(12), 1743. https://doi.org/10.3390/vaccines11121743

McCosker, L. K., El-Heneidy, A., Seale, H., Ware, R. S., & Downes, M. J. (2022). Strategies to improve vaccination rates in people who are homeless: a systematic review. Vaccine, 40(23), 3109-3126. https://doi.org/10.1016/j.vaccine.2022.04.022